Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Natalizumab For Iv Inj Conc 300 Mg/15ml (CDM Rx64406000801) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 11, 2026 , from http://ppman.hank.ai/transparency/procedure/Rx64406000801/by-state?code_type=CDM
“Natalizumab For Iv Inj Conc 300 Mg/15ml (CDM Rx64406000801) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/Rx64406000801/by-state?code_type=CDM. Accessed
October 11, 2026 .
“Natalizumab For Iv Inj Conc 300 Mg/15ml (CDM Rx64406000801) by State,” HANK Price Transparency ,
accessed October 11, 2026 ,
http://ppman.hank.ai/transparency/procedure/Rx64406000801/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
Rx64406000801 — Natalizumab For IV Inj Conc 300 Mg/15ml
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$21,257
National median
$20,194 – $21,257
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for Rx64406000801 (CDM), with interquartile range
State Median p25 p75
WA $21,257 $20,194 $21,257